Anthropic's robust financial position and rapid scaling make near-term bankruptcy highly improbable in trader assessments. The company secured a $65 billion Series H round in May 2026 at a $965 billion post-money valuation, pushing annualized revenue run rate past $47 billion with 14-fold year-over-year growth and positive adjusted operating income for consecutive quarters. It is finalizing a $15 billion pre-IPO credit facility while advancing Claude models, including AI-assisted R&D where the system now leads 26% of internal work, alongside enterprise partnerships such as the recent Novo Nordisk collaboration for drug discovery. Preparations for an October 2026 IPO, massive compute commitments exceeding $500 billion, and ongoing model releases further underscore capital access and competitive momentum that would require extraordinary reversals to threaten solvency.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于$28,175 交易量

2027年12月31日
7%

2028年12月31日
16%

2029年12月31日
21%
$28,175 交易量

2027年12月31日
7%

2028年12月31日
16%

2029年12月31日
21%
市场开放时间: Sep 17, 2026, 6:37 PM ET
Anthropic's robust financial position and rapid scaling make near-term bankruptcy highly improbable in trader assessments. The company secured a $65 billion Series H round in May 2026 at a $965 billion post-money valuation, pushing annualized revenue run rate past $47 billion with 14-fold year-over-year growth and positive adjusted operating income for consecutive quarters. It is finalizing a $15 billion pre-IPO credit facility while advancing Claude models, including AI-assisted R&D where the system now leads 26% of internal work, alongside enterprise partnerships such as the recent Novo Nordisk collaboration for drug discovery. Preparations for an October 2026 IPO, massive compute commitments exceeding $500 billion, and ongoing model releases further underscore capital access and competitive momentum that would require extraordinary reversals to threaten solvency.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于


警惕外部链接哦。
警惕外部链接哦。
常见问题